KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Assets (2016 - 2025)

Exact Sciences has reported Assets over the past 16 years, most recently at $5.9 billion for Q4 2025.

  • Quarterly Assets fell 1.14% to $5.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 billion through Dec 2025, down 1.14% year-over-year, with the annual reading at $5.9 billion for FY2025, 1.14% down from the prior year.
  • Assets was $5.9 billion for Q4 2025 at Exact Sciences, down from $5.9 billion in the prior quarter.
  • Over five years, Assets peaked at $6.7 billion in Q3 2024 and troughed at $5.7 billion in Q1 2025.
  • The 5-year median for Assets is $6.4 billion (2023), against an average of $6.3 billion.
  • Year-over-year, Assets skyrocketed 52.82% in 2021 and then dropped 13.13% in 2025.
  • A 5-year view of Assets shows it stood at $6.7 billion in 2021, then dropped by 6.85% to $6.2 billion in 2022, then grew by 3.93% to $6.5 billion in 2023, then decreased by 8.39% to $5.9 billion in 2024, then dropped by 1.14% to $5.9 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Assets are $5.9 billion (Q4 2025), $5.9 billion (Q3 2025), and $5.8 billion (Q2 2025).